Aller au contenu
Varieties from the European CatalogueGrown in FranceSlow dryingSame-day dispatch — before noonEU delivery — 24-72 hRight of withdrawal — 14 daysCertificate available — per batch

← Journal/Lifestyle·13 August 2026·6 min de lecture

Best CBD in 2026: the grid of criteria you can verify

Par ·

There is no such thing as the "best CBD" in the absolute — there are products whose promises can be verified and products whose promises cannot. The most reliable method for choosing comes down to seven criteria, all checkable by anyone in a few minutes: the batch certificate of analysis, the gap between measured and advertised content, Δ⁹-THC compliance, the source variety, traceability, the price brought back to the gram, and the seller's commercial transparency.

Why rankings are not enough

Searching for "best CBD" mostly returns rankings: top-10 site lists, shop comparisons, annual league tables. These formats have a structural limit — their ordering criteria are not reproducible by the reader. You can neither redo the test, nor verify the score, nor know what weighed in the ranking.

A criteria grid takes the problem the other way round: it does not say who is best, it says how to verify what a product claims. Each criterion below is falsifiable — a product either meets it or does not, and anyone can run the check.

The grid: seven criteria that can be verified

1. The batch certificate of analysis — published, not promised

The first criterion on its own eliminates most of the market: does the seller publish the certificate of analysis for the precise batch you are buying? Not a generic certificate for the variety, not an analysis from two years ago: the one for the batch on sale, dated, with the laboratory's name.

A "laboratory tested" claim without a viewable document is not proof, it is a slogan. The analysis method matters too: HPLC chromatography is the reference for quantifying cannabinoids, because it measures the acidic forms without converting them through heat.

2. Measured content against advertised content

A product displays "CBD 20%": the batch certificate must show a measured figure, and the gap between the two can be read directly. A round figure, identical across all batches, with no decimal, is a warning signal — a real measurement varies from batch to batch.

This is the criterion that separates a name from a data point. A seller who displays the certificate's figure, decimals included, owns the plant's natural variation; a seller who displays the same "20%" everywhere is displaying a sales argument.

3. Δ⁹-THC compliance: below 0.30%, measured

In France, the framework is quantified: products must come from varieties whose Δ⁹-tetrahydrocannabinol content does not exceed 0.30% (decree of 30 December 2021). The threshold also applies to extracts and to the products that incorporate them — and here again, only the batch analysis attests to it. The detail of the threshold and its measurement is covered in our dedicated article on the 0.30%.

4. The variety: listed in the EU Common Catalogue

A compliant flower or extract comes from a hemp variety listed in the Common Catalogue of varieties. A serious seller can say which variety their batch comes from; "exclusive genetics" without a listed variety name is not an answer. What the word CBD (cannabidiol) covers exactly — and what distinguishes it from the other cannabinoids — is documented entry by entry in our encyclopedia.

5. Traceability: the batch's origin and journey

Where does the batch come from, who packaged it, when? Traceability requires no industrial secrets: a country of origin, a packaging date, a batch number linking the pouch to the certificate. If the batch number on the product received matches no document, criterion 1 collapses retroactively.

6. The price brought back to the gram — the only comparable figure

Displayed prices compare poorly: different pouch sizes, promotions, volume discounts. The only comparable figure is the price per gram at the tier you actually buy. A "slashed price" on 1 g can cost more per gram than a standard rate on 10 g. The calculation takes ten seconds and neutralises most of the promotional theatre.

7. The seller's commercial transparency

The last criterion, and the rarest: does the seller explain how their price is built? A stated margin, a stable pricing policy rather than permanent promotions, delivery and return conditions readable before purchase. A merchant who shows their pricing mechanics has no need to hide it behind a countdown timer.

Applying the grid in five minutes

  1. Open the product page and look for the certificate of analysis for the batch — if absent, the check stops there.
  2. Compare advertised and measured content, decimals included.
  3. Check the certificate's Δ⁹-THC line: below 0.30%.
  4. Ask for (or read) the variety name and the batch's origin.
  5. Bring the price back to the gram, at the tier actually bought.
  6. Read what the seller says about their prices and margin.

A product that passes the first six points without friction is, in the verifiable sense of the term, a good product — whatever ranking its seller appears in.

Frequently asked questions

Which CBD should you choose to start with?

The one whose evidence is readable: a published batch certificate, a measured content consistent with the claim, a named variety. The format (flower, oil, resin) is a matter of use and preference — the verification grid, for its part, does not change from one format to another.

Is a "premium" CBD better?

"Premium" is a label, not a measurement. The word appears on no certificate of analysis. If the so-called premium product meets the seven criteria, it is the grid that shows it — not the label.

Does a high price guarantee quality?

No, and a low price does not disqualify it. Price reflects costs (cultivation, separation, analyses, the seller's structure) and commercial choices. It is the gap between promise and certificate that measures quality — the price per gram is for comparing, not judging.

Sources


Written by the Phytogrammes team

Every article in this journal draws on primary sources (ANSM, EFSA, EUR-Lex, peer-reviewed publications) and on the lab's own practice: batch-by-batch HPLC analyses, measured cannabinoid profiles. Our approach.

Article published on . CBD is not a medicine.

Phytogrammes products that pair well